Role of miRNAs in Immune-Related Disorders
A systematic review discussed how microRNAs (miRNAs) are important in regulating immune cells and maintaining immune balance. This research highlighted their potential as biomarkers for diagnosing and predicting immune-related diseases, and their promise as therapeutic targets.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
Understanding the role of miRNAs in immune disorders may lead to better diagnostics and treatment strategies for conditions like multiple sclerosis, aiding in early disease detection and monitoring.
What this does not prove
The review does not provide specific evidence or results about the effectiveness of miRNA-based treatments in MS, nor does it detail outcomes from clinical trials.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-04
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceMicroRNAs in immune-related diseases: mechanism, functions and therapeutic perspectives. ↗DOI: 10.3389/fimmu.2026.1943071
Supporting passages (6)
study designIn this review, we comprehensively discuss the biogenesis and biological functions of miRNAs and examine their regulatory roles in the pathogenesis of rheumatoid arthritis (RA), inflammatory bowel disease (IBD), multiple sclerosis (MS), psoriasis, systemic lupus erythematosus (SLE), and atopic dermatitis (AD).
peer reviewedJournal: Frontiers in immunology
findingsAccumulating evidence has highlighted the pivotal role of miRNAs in the development, differentiation, and function of immune cells, as well as in maintaining immune homeostasis.
findingsThese characteristics make circulating miRNAs promising candidates as diagnostic biomarkers for the early detection of disease and as prognostic indicators for disease progression and evaluating therapeutic efficacy.
limitationsThese six diseases constitute the cluster of "immune-related disorders," where miRNA-based studies are steadily increasing, and these molecules hold the highest potential as novel therapeutic targets.
publication datePublication date: 2026-09-04
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.